Such insights not only advance our understanding of BTBD19’s role in colorectal oncogenesis but also highlight actionable pathways for therapeutic intervention, guiding future studies to explore BTBD19 as a potential biomarker or therapeutic target in CRC. Here, BTBD19 is linked to colorectal carcinoma.